News Releases
WEBINAR: The Use of Enzymes in the Production of Peptide API
Learn in this webinar how enzymes enable greener peptide syntheses and what questions appear around the use of enzymes in a GMP setting.
The use of enzymes is a key component in making manufacturing routes of active pharmaceutical ingredients (APIs) more sustainable and environmentally friendly. Learn in this webinar how enzymes - used for chemo-enzymatic peptide synthesis produced by EnzyTag - enable greener peptide syntheses and what questions appear around the use of enzymes in a GMP setting: Which control strategies and regulatory considerations have to be taken into account? Which risk assessments are in place?
More News Releases by Bachem
More Content From Bachem
-
Thursday, May 22, 2024 - 5:00 PM CET / 8:00 AM PST / 11:00 AM EST
-
Learn how the polarity and viscosity profiles of binary solvents can be used to predict their utility for producing different peptides by SPPS.
-
Scientists seek to discover new production routes when manufacturing limits arise.
-
Bachem Develops a Cost-Effective, Large-Batch Process for Octreotide Acetate Synthesis
-
Bachem's experts share their analytical expertise on peptide aggregation and how to avoid it through optimized downstream process conditions.
-
Direct, robust and easy-to-use techniques to fully characterize the nucleotide sequence of highly modified single-stranded RNAs by top down tandem MS.
-
The pros and cons of today’s technologies for SPPS, native chemical ligation, CEPS, KAHA and recombinant technologies.
-
Learn how to reach commercial oligonucleotides API production in metric ton range with unbeaten process mass intensity and much more.
-
The peptide drug market has experienced significant growth in recent years and is expected to continue its upward trend in the coming years.
-
Solid phase peptide synthesis (SPPS) is a technique for peptide synthesis.
-
An interview with Sergey Malashikhin of Bachem on what’s behind the manufacturing of complex APIs.
-
Continuous chromatography is a promising solution due to its high productivity, improved selectivity, and reduced costs.
-
It is currently used as an active pharmaceutical ingredient in prescription medicines for the treatment of type II diabetes and Obesity.
-
This tour is an exclusive walkthrough of Bachem’s oligonucleotide facilities in the company’s Headquarters, Bubendorf, Basel, Switzerland.
-
Register for the Webinar on Thursday, February 23rd 2023, 5:30pm CET / 8:30am PST / 11:30am EST